SARS-CoV-2 hybrid immunity CDR profiling
downstream-application
SARS-CoV-2 hybrid immunity CDR profiling: downstream-application. LC-MS/MS profiling of complementarity determining regions of anti-RBD antibodies, partly by de novo sequencing, separates hybrid-immunity CDR profiles from…
LC-MS/MS profiling of complementarity determining regions of anti-RBD antibodies, partly by de novo sequencing, separates hybrid-immunity CDR profiles from vaccination-only ones.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Application area | Antibodyomics |
Paper describing it
- Complementarity determining regions in SARS-CoV-2 hybrid immunity (2023, Frontiers in Immunology, peer-reviewed)